![](/img/cover-not-exists.png)
Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis
Prather, Caitlin, Adams, Erin, Zentgraf, WhitneyJournal:
American Journal of Health-System Pharmacy
DOI:
10.1093/ajhp/zxaa285
Date:
September, 2020
File:
PDF, 188 KB
2020